We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Beckman Coulter Announces CE Mark for Hematology Analyzer

By LabMedica International staff writers
Posted on 30 Apr 2018
Print article
Image: The DxH 520 is designed to help low-volume labs enhance patient care through increased productivity with reduced costs (Photo courtesy of Beckman Coulter Diagnostics).
Image: The DxH 520 is designed to help low-volume labs enhance patient care through increased productivity with reduced costs (Photo courtesy of Beckman Coulter Diagnostics).
Beckman Coulter (Brea, CA, USA) announced achievement of CE Mark for its DxH 520 hematology analyzer, designed to help physician office laboratories deliver high-quality results with increased productivity and ease. With as little as two environmentally friendly reagents, the compact five-part differential system enhances efficiency and resource management through a comprehensive feature set that automates daily tasks. This reduces the amount of time spent on laboratory operations and frees time for patient care.

The DxH 520 complements Beckman Coulter's wide-ranging product portfolio, delivering performance and functionality to meet the needs of clinical laboratories of all sizes—from low- to ultra-high volume. The company used its time-proven flagship DxH 800 hematology solution as the predicate method for the DxH 520 system, establishing a strong correlation throughout the entire DxH line of hematology analyzers. This provides a high level of continuity of care for clinical laboratories, regardless of whether they are small- or high-volume facilities.

Laboratories with low-volume workloads are under increased pressure to deliver high-quality patient care with greater operational efficiency. The DxH 520 analyzer strengthens clinical decision-making with its proprietary dynamic-gating method that improves sample flagging, and reduces slide reviews and technical interpretation, while maintaining effective clinical sensitivity.

As an upgrade from a three-part to a five-part differential instrument, the DxH 520 analyzer gives the clinician more information by which to make decisions when assessing a patient. A robust IT and data-management package helps reduce clerical errors and inefficiencies, and allows for easy retrieval of up to 30,000 patient samples. The system’s small 17-microliter aspiration is ideal for puncture samples from infants, geriatric, oncology, and critical care patients. Closed tube aspiration capability both simplifies analysis and ensures safety for laboratory technologists by eliminating sample exposure.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more